These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37359924)

  • 1. Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database.
    Rijken A; Galanos LJK; Burger JWA; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):60-66. PubMed ID: 37359924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated Incidence, Treatment and Survival of a Nationwide Cohort of Patients with Peritoneal Metastases of Unknown Origin.
    Rijken A; Loef C; van de Wouw YAJ; van Erning FN; de Hingh IHJT
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):67-73. PubMed ID: 37359941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
    Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
    Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
    Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal metastases from extra-abdominal cancer - A population-based study.
    Flanagan M; Solon J; Chang KH; Deady S; Moran B; Cahill R; Shields C; Mulsow J
    Eur J Surg Oncol; 2018 Nov; 44(11):1811-1817. PubMed ID: 30139510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
    Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
    Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
    Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
    Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
    Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
    Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
    Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study.
    Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT
    Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort.
    Rijken A; Bakkers C; van Erning FN; van der Geest LG; de Vos-Geelen J; Besselink MG; Lemmens VE; de Hingh IHJT;
    Pancreas; 2021 Jul; 50(6):827-833. PubMed ID: 34347730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.
    de Boer NL; Rovers K; Burger JWA; Madsen EVE; Brandt-Kerkhof ARM; Kok NFM; de Wilt JHW; de Reuver PH; Bos A; de Hingh IHJT; Verhoef C
    Cancer Med; 2020 Aug; 9(16):5851-5859. PubMed ID: 32614506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?
    Uppal A; Helmink B; Grotz TE; Konishi T; Fournier KF; Nguyen S; Taggart MW; Shen JP; Bednarski BK; You YN; Chang GJ
    Ann Surg Oncol; 2022 Mar; ():. PubMed ID: 35307803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
    Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
    Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Characteristics of Endometrial Cancer With Extraperitoneal Metastasis and the Value of Surgery in Treatment.
    Guo J; Cui X; Zhang X; Qian H; Duan H; Zhang Y
    Technol Cancer Res Treat; 2020; 19():1533033820945784. PubMed ID: 32721274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
    Rijken A; van de Vlasakker VCJ; Simkens GA; Rovers KP; van Erning FN; Koopman M; Verhoef C; de Wilt JHW; de Hingh IHJT
    Clin Exp Metastasis; 2023 Aug; 40(4):289-298. PubMed ID: 37209222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods.
    Yarema R; Оhorchak М; Hyrya P; Kovalchuk Y; Safiyan V; Karelin I; Ferneza S; Fetsych M; Matusyak M; Oliynyk Y; Fetsych Т
    World J Gastrointest Oncol; 2020 May; 12(5):569-581. PubMed ID: 32461788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.
    Matsuda K; Hotta T; Takifuji K; Yamamoto M; Nasu T; Togo N; Oka M; Tabuse K; Yamaue H
    Surgery; 2012 Feb; 151(2):238-44. PubMed ID: 21176934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.